Effectiveness of antidepressants in improving the prognosis of COVID-19: A systematic review and meta-analysis
Ver/
Fecha
2024Autor
Cobos Campos, Raquel
Sáez De La Fuente Moriñigo, Arantza
Cordero Guevara, José Aurelio
Bermúdez Ampudia, Cristina
Parraza Díez, Naiara
Metadatos
Mostrar el registro completo del ítem
Atención Primaria 56 : (2024) // Article ID 102771
Resumen
Objective,
and
material
and
methods:
A
systematic
review
and
meta-analysis
was
performed
to
evaluate
the
effectiveness
of
antidepressants
in
reducing
the
poor
evolution
of
COVID-19
disease
(a
composite
variable
including
death,
hospitalization
and
need
for
mechanical
ventila-
tion),
and
mortality,
according
the
guidelines
for
Systematic
Reviews
of
Interventions
published
by
the
Cochrane
library.
Source
of
data:
MEDLINE,
EMBASE
and
COCHRANE
LIBRARY
were
consulted
up
to
February
25,
2022.
Unpublished
studies
were
searched
on
clinicaltrials.gov
platform.
Selection
of
studies:
Seven
masked
and
unmasked,
observational
and
experimental
studies
evaluating
death,
hospitalization
and
need
for
mechanical
ventilation
were
selected.
A
second
subgroup
analysis
with
mortality
variable
was
performed.
Data
extraction:
A
full
risk
of
bias
assessment
was
performed
addressing
issues
such
as
informa-
tion
and
confounding
bias.
ROB2
and
Robins-I
tools
for
randomized
and
no
randomized
studies
were
employed
respectively.
In
the
quantitative
analysis,
the
risk
of
publication
bias,
hetero-
geneity,
estimation
of
pooled
measure
and
a
sensitivity
analysis
was
performed.
The
pooled
final
measure
was
calculated
as
odds
ratio
with
its
correspondent
95%
confidence
interval.
A
random
effects
model
was
used
for
this
purpose
due
to
the
heterogeneity
between
included
studies.
Finally,
a
sensitivity
analysis
was
performed
to
assess
the
robustness
of
final
pooled
measure.
Results:
Seven
studies
were
finally
considered
to
calculate
the
final
pooled
measure.
The
effect
of
intervention
was
OR
0.73;
95%
CI
0.56---0.94.